Home › OncoMed moves forward on drug trials halted due to side effects
 

Keywords :   


OncoMed moves forward on drug trials halted due to side effects

2014-09-05 08:39:41| Chemicals - Topix.net

For the second time in a week, the Food and Drug Administration lifted a hold on three early-stage clinical trials of an experimental cancer-fighting drug by OncoMed Pharmaceuticals Inc. The studies are important for Redwood City-based OncoMed because partner Bayer HealthCare has the option under a 2010 deal to an exclusive license of the drugs after the trials are completed. Enrollment in both programs, halted in June , is expected to be under way again soon, OncoMed Chairman and CEO Paul Hastings said late Thursday afternoon.

Tags: due side forward effects

Category:Chemicals

Latest from this category

All news
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06WEG Mexico Obtains Quality Certificate from QUALICOAT
26.06Cool Roof Coatings Market to Reach US$9.2B by 2030: Fairfield
25.06Briolf Group to Invest $30 Million in Its First US Production Plant
25.06Sherwin-Williams Announces 2023 Water and Wastewater Impact Award Winners
Chemicals »
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
26.06Companies Seek Federal EPR: How Producers Can Prepare
26.06Q&A with GFLs Tyler Stefure: Integrating New Fleet Tech & Upholding GFL Values
More »